About the 2022 Program
The 2022 Biotech Showcase program will include in-person sessions January 10–12, 2022 in San Francisco. Select program sessions will be released on our proprietary partneringONE® platform as early as mid-December.
Going live nearly two years after the COVID-19 pandemic first started, the 2022 program will feature insights from top investors and biopharma executives by:
Examining how the biopharma industry can accelerate drug discovery and manufacturing to prepare for future pandemics.
Providing updates in hot therapeutic areas such as oncology, CNS, cell and gene therapy, rare disease.
Exploring how COVID-19 accelerated the adoption of all things digital through the Digital Medicine & Medtech Showcase program.
Showcasing the promise of early-stage innovation through the Seed Showcase program.
The 2022 program dates and times will be released by early fall of 2021.
2021 Program Highlights
Hours of session content
THE BIOTECH SHOWCASE FAMILY OF EVENTS
Your Biotech Showcase registration showcase registration gives you access Biotech Showcase, Digital Medicine and Medtech Showcase and Seed Showcase content. China Showcase is a separate registration.
View these 2021 sessions
INVESTING IN DIVERSITY
RARE BEYOND THE SQUARE
From de-risking to value creation – The evolving role of patient communities in rare disease drug development and commercialization